See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI102.40▲ 2.95%
← 0MGG page
XStocksXray
Market X-Ray report · 22 October 2026

Kemira Oyj (0MGG)

London Exchange · UK · prices in EUR · close of 22 Oct 2026

Key indicators

Last closeEUR 15.97
52-week range15.94 – 21.28
Return, 1 month / 3 months−9.2% / −5.9%
Return, 1 year / 3 years−14.4% / +15.9%
TrendBelow its 200-day average
RSI (14)27
Volatility (1 year)23.5%
Worst drawdown (1 year)-24.8%
Average daily value traded0.83M EUR
Dividend yield2.3%

Market X-Ray price-based

44/ 100 · High confidence · ahead of 37% of stocks on this exchange
Trend30
Momentum32
Stability (higher is calmer)70
Liquidity51
Income40

Five-year price chart navy: price · brown: 200-day average

8.5212.2816.0519.8223.592021-102023-012024-032025-062026-10

About the company

Kemira Oyj is a Finnish chemicals company based in Helsinki. It supplies water treatment chemicals for drinking water and wastewater, and process chemicals for the pulp and paper industry, along with products for oil, gas and mining customers. Its customers include municipalities, industrial plants and paper producers, and it serves markets across Europe and other regions.

On this site Kemira Oyj appears as a stock on the London Exchange (UK), code 0MGG, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Kemira Oyj (0MGG) trades on the London Exchange in UK. It last closed at EUR 15.97 on 22 October 2026.

Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,379 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 14.4% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Kemira Oyj (0MGG)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend30 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-12.3%
From 52-week high-24.8%
Momentum32 · WeakLagging most stocks on this exchange.
3-month return-5.9%
6-month return-17.2%
12-month return, skipping the last month-5.6%
Stability (higher is calmer)70 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)23.5%
Worst drawdown, 1 year (smaller is calmer)-24.8%
Liquidity51 · FairModerate trading activity.
Average daily value traded0.83M EUR
Zero-volume days0.0%
Income40 · WeakDividend is small or irregular.
Dividend yield2.3%
Years with dividends5

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Income: Dividend is small or irregular.

Returns

1 week−4.2%
1 month−9.2%
3 months−5.9%
6 months−17.2%
1 year−14.4%
3 years+15.9%
5 years+40.2%

Signals

50-day / 200-day average17.22 / 18.21
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.33

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

Recent dividends

Ex-dividend dateAmount per share
27 Oct 2025EUR 0.3700
21 Mar 2025EUR 0.3700
28 Oct 2024EUR 0.3400
21 Mar 2024EUR 0.3400
25 Oct 2023EUR 0.3100
23 Mar 2023EUR 0.3100

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026